Acute Renal Failure/Acute Kidney Injury Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Acute Renal Failure/Acute Kidney Injury Epidemiology Forecast Report Coverage

Expert Market Research's “Acute Renal Failure/Acute Kidney Injury Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of acute renal failure/acute kidney injury. It projects the future incidence and prevalence rates of acute renal failure/acute kidney injury cases across various populations. The study covers age, gender, and type as major determinants of the acute renal failure/acute kidney injury population. The report highlights patterns in the prevalence of acute renal failure/acute kidney injury over time and projects future trends based on multiple variables.

Acute Renal Failure/Acute Kidney Injury Understanding: Disease Overview

Acute kidney injury is a sudden decline in kidney function, leading to accumulation of waste products, electrolyte imbalances, and fluid dysregulation. It may result from pre-renal causes (reduced perfusion), intrinsic renal damage (tubular necrosis, glomerulonephritis), or post-renal obstruction. AKI can occur across all age groups, with higher risk among hospitalized or critically ill patients. Prompt recognition is critical, as untreated AKI can progress to chronic kidney disease or end-stage renal failure, increasing morbidity, mortality, and healthcare burden globally.

Acute Renal Failure/Acute Kidney Injury Epidemiology Perspective

The acute renal failure/acute kidney injury epidemiology division offers information on the patient pool from history to the present, as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the acute renal failure/acute kidney injury epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for acute renal failure/acute kidney injury and their trends. The acute renal failure/acute kidney injury detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• A 2024 estimate suggested around 13.3 million new AKI cases occur annually worldwide, reflecting a substantial global burden across both community and hospital settings.
• In high-income countries, AKI largely affects the elderly and those with chronic comorbidities. Most cases are hospital-acquired and related to surgery, sepsis, contrast exposure, or drug-induced nephrotoxicity. Despite greater resources, severe AKI still carries mortality rates of 40-60% in ICU settings.
• In low- and middle-income countries (LMICs), it often affects younger individuals, including children and young adults. Up to 80% of cases in some LMICs are community-acquired. Common causes include dehydration, diarrheal illnesses, malaria, leptospirosis, obstetric complications, traditional/herbal toxins, and snakebites.
• In sub-Saharan Africa and parts of South Asia, mortality from AKI can exceed 50–70%, primarily due to delayed diagnosis and limited access to dialysis.
• Recent population-based estimates suggest that the global incidence of acute kidney injury and acute kidney disease ranges between 114 and 174 cases per 10,000 person-years, reflecting variability due to differences in diagnostic criteria and surveillance methodologies.
• AKI primarily affects older adults aged 60 years and above, whereas younger populations in low-resource regions experience higher infection-related AKI rates.

Read more about this report - Request a Free Sample

Country-wise Acute Renal Failure/Acute Kidney Injury Epidemiology Segment

The acute renal failure/acute kidney injury epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

In the United States, the epidemiology of acute renal failure, clinically referred to as acute kidney injury (AKI), reflects a significant and growing healthcare concern. According to the U.S. Renal Data System 2023 Annual Data Report, the nation recorded an estimated 62.5 hospitalizations with AKI per 1,000 person-years in 2021. This underscores the substantial burden of kidney injury within the healthcare system, particularly among hospitalized and critically ill populations. Ongoing surveillance and preventive strategies remain essential to mitigate the rising clinical and economic impact of AKI across the country.

Acute Renal Failure/Acute Kidney Injury: Treatment Overview

Management of AKI involves identifying and treating the underlying cause, ensuring hemodynamic stability, and correcting electrolyte and acid-base imbalances. Supportive care may include fluid management, avoidance of nephrotoxic agents, and nutritional support. In severe cases, renal replacement therapy (hemodialysis or continuous renal replacement) is indicated. Pharmacologic interventions focus on diuretics for fluid overload and vasopressors for hypotension. Early intervention and monitoring can reduce progression to chronic kidney disease, optimize recovery, and improve survival outcomes in hospitalized and high-risk patients.

Key Questions Answered

• What are the key findings of acute renal failure/acute kidney injury epidemiology in the 8 major markets?
• What will be the total number of patients with acute renal failure/acute kidney injury across the 8 major markets during the forecast period?
• What was the country-wise acute renal failure/acute kidney injury epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of cases of acute renal failure/acute kidney injury during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of acute renal failure/acute kidney injury during the forecast period of 2026-2035?
• What are the currently available treatments for acute renal failure/acute kidney injury?
• What are the disease risks, signs, symptoms, and unmet needs of acute renal failure/acute kidney injury?

Scope of the Acute Renal Failure/Acute Kidney Injury Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of acute renal failure/acute kidney injury based on several factors.
• Acute Renal Failure/Acute Kidney Injury Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The acute renal failure/acute kidney injury report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Chronic Renal Failure Therapeutic Market

Acute Kidney Injury Treatment Market